MN SF272 | 2019-2020 | 91st Legislature

Status

Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on January 17 2019 - 25% progression, died in committee
Action: 2019-01-28 - Author added Newton
Pending: Senate Health and Human Services Finance and Policy Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Price gouging by drug manufacturer or wholesale distributor prohibition; pharmacy board, human services commissioner and health plan companies notification of prescription drug price increases to the attorney general authorization; attorney general drug pricing information access and action against drug manufacturers and wholesalers authorization; civil penalties imposition

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Price gouging by drug manufacturer or wholesale distributor prohibition; pharmacy board, human services commissioner and health plan companies notification of prescription drug price increases to the attorney general authorization; attorney general drug pricing information access and action against drug manufacturers and wholesalers authorization; civil penalties imposition

Sponsors


History

DateChamberAction
2019-01-28SenateAuthor added Newton
2019-01-24SenateAuthor added Marty
2019-01-17SenateReferred to Health and Human Services Finance and Policy
2019-01-17SenateIntroduction and first reading

Minnesota State Sources


Bill Comments

feedback